212 related articles for article (PubMed ID: 11028489)
1. Glycoprotein IIIa Pl(A1/A2) polymorphism and sudden cardiac death.
Mikkelsson J; Perola M; Laippala P; Penttilä A; Karhunen PJ
J Am Coll Cardiol; 2000 Oct; 36(4):1317-23. PubMed ID: 11028489
[TBL] [Abstract][Full Text] [Related]
2. Glycoprotein IIIa Pl(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly.
Mikkelsson J; Perola M; Laippala P; Savolainen V; Pajarinen J; Lalu K; Penttilä A; Karhunen PJ
Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2573-8. PubMed ID: 10521390
[TBL] [Abstract][Full Text] [Related]
3. The GPIIIa (beta3 integrin) PlA polymorphism in the early development of coronary atherosclerosis.
Mikkelsson J; Perola M; Penttilä A; Goldschmidt-Clermont PJ; Karhunen PJ
Atherosclerosis; 2001 Feb; 154(3):721-7. PubMed ID: 11257275
[TBL] [Abstract][Full Text] [Related]
4. Platelet glycoprotein Ibalpha HPA-2 Met/VNTR B haplotype as a genetic predictor of myocardial infarction and sudden cardiac death.
Mikkelsson J; Perola M; Penttilä A; Karhunen PJ
Circulation; 2001 Aug; 104(8):876-80. PubMed ID: 11514372
[TBL] [Abstract][Full Text] [Related]
5. PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement.
Kastrati A; Koch W; Gawaz M; Mehilli J; Böttiger C; Schömig K; von Beckerath N; Schömig A
J Am Coll Cardiol; 2000 Jul; 36(1):84-9. PubMed ID: 10898417
[TBL] [Abstract][Full Text] [Related]
6. [Polymorphism of GPIIIA platelet glycoprotein gene PIA1/A2 compared to plasma hemostasis in myocardial infarction patients].
Tereshchenko SN; Levchuk NN; Drozdov VN; Shaĭkhaev GO; Leont'ev SG; Kirienko AI; Moiseev VS
Ter Arkh; 1999; 71(9):66-70. PubMed ID: 10553630
[TBL] [Abstract][Full Text] [Related]
7. Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets.
Bennett JS; Catella-Lawson F; Rut AR; Vilaire G; Qi W; Kapoor SC; Murphy S; FitzGerald GA
Blood; 2001 May; 97(10):3093-9. PubMed ID: 11342435
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly.
Mikkelsson J; Perola M; Wartiovaara U; Peltonen L; Palotie A; Penttilä A; Karhunen PJ
Thromb Haemost; 2000 Jul; 84(1):78-82. PubMed ID: 10928474
[TBL] [Abstract][Full Text] [Related]
9. Platelet collagen receptor GPIa (C807T/HPA-5) haplotype is not associated with an increased risk of fatal coronary events in middle-aged men.
Mikkelsson J; Perola M; Penttilä A; Karhunen PJ
Atherosclerosis; 2002 Nov; 165(1):111-8. PubMed ID: 12208476
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of the platelet glycoprotein IIIa Pl(A1/A2) polymorphism in three South African ethnic groups and its effect on platelet function.
Naran NH; Chetty N; Crowther NJ
Thromb Res; 2008; 123(2):316-23. PubMed ID: 18657307
[TBL] [Abstract][Full Text] [Related]
11. Platelet membrane collagen receptor glycoprotein VI polymorphism is associated with coronary thrombosis and fatal myocardial infarction in middle-aged men.
Ollikainen E; Mikkelsson J; Perola M; Penttilä A; Karhunen PJ
Atherosclerosis; 2004 Sep; 176(1):95-9. PubMed ID: 15306180
[TBL] [Abstract][Full Text] [Related]
12. Higher prevalence of GPIIIa PlA2 polymorphism in siblings of patients with premature coronary heart disease.
Goldschmidt-Clermont PJ; Coleman LD; Pham YM; Cooke GE; Shear WS; Weiss EJ; Kral BG; Moy TF; Yook RM; Blumenthal RS; Becker DM; Becker LC; Bray PF
Arch Pathol Lab Med; 1999 Dec; 123(12):1223-9. PubMed ID: 10583927
[TBL] [Abstract][Full Text] [Related]
13. Association between the Pl(A) platelet glycoprotein GPIIIa polymorphism and extent of coronary artery disease.
Gruchała M; Ciećwierz D; Ochman K; Targoński R; Dubaniewicz W; Sobiczewski W; Wasag B; Drewla P; Skarzynski P; Romanowski P; Limon J; Rynkiewicz A
Int J Cardiol; 2003 Apr; 88(2-3):229-37. PubMed ID: 12714203
[TBL] [Abstract][Full Text] [Related]
14. Platelet glycoprotein IIb/IIIa polymorphism and coronary artery disease: implications for clinical practice.
Di Castelnuovo A; de Gaetano G; Benedetta Donati M; Iacoviello L
Am J Pharmacogenomics; 2005; 5(2):93-9. PubMed ID: 15813672
[TBL] [Abstract][Full Text] [Related]
15. The impact of genetic variation in the region of the GPIIIa gene, on Pl expression bias and GPIIb/IIIa receptor density in platelets.
O'Halloran AM; Curtin R; O'Connor F; Dooley M; Fitzgerald A; O'Brien JK; Fitzgerald DJ; Shields DC
Br J Haematol; 2006 Feb; 132(4):494-502. PubMed ID: 16412022
[TBL] [Abstract][Full Text] [Related]
16. Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study.
Bojesen SE; Juul K; Schnohr P; Tybjaerg-Hansen A; Nordestgaard BG;
J Am Coll Cardiol; 2003 Aug; 42(4):661-7. PubMed ID: 12932598
[TBL] [Abstract][Full Text] [Related]
17. The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans.
Hooper WC; Lally C; Austin H; Benson J; Dilley A; Wenger NK; Whitsett C; Rawlins P; Evatt BL
Chest; 1999 Oct; 116(4):880-6. PubMed ID: 10531147
[TBL] [Abstract][Full Text] [Related]
18. The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction.
Bray PF; Cannon CP; Goldschmidt-Clermont P; Moyé LA; Pfeffer MA; Sacks FM; Braunwald E
Am J Cardiol; 2001 Aug; 88(4):347-52. PubMed ID: 11545752
[TBL] [Abstract][Full Text] [Related]
19. Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease.
Carter AM; Ossei-Gerning N; Wilson IJ; Grant PJ
Circulation; 1997 Sep; 96(5):1424-31. PubMed ID: 9315527
[TBL] [Abstract][Full Text] [Related]
20. The effect of glycoprotein IIIa A1/A2 gene polymorphism on one-year outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Kozieradzka A; Kamiński KA; Pepiński W; Janica J; Korecki J; Skolimowski K; Frankowska E; Kralisz P; Bonda TA; Dobrzycki S; Musiał WJ
Kardiol Pol; 2006 Dec; 64(12):1350-5; discussion 1356. PubMed ID: 17206538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
